Cyclerion Therapeutics (CYCN) Current Leases (2019 - 2021)

Cyclerion Therapeutics' Current Leases history runs 3 years deep, the most recent figure standing at $1.4 million for Q1 2021.

• In Q1 2021, Current Leases fell 47.53% year-over-year to $1.4 million; the TTM figure through Mar 2021 stood at $1.4 million (down 47.53% YoY), while the FY2020 annual figure was $3.3 million, down 3.71% from the prior year.
• Current Leases was $1.4 million for Q1 2021 at Cyclerion Therapeutics, down from $3.3 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $3.4 million in Q4 2019 to a low of $866000.0 in Q2 2019.
• Historically, Current Leases has averaged $2.6 million across 3 years, with a median of $3.0 million in 2020.
• The sharpest annual moves came in 2020 and 2021: Current Leases jumped 221.82% in 2020, then tumbled 47.53% in 2021.
• A 3-year view of Current Leases shows it stood at $3.4 million in 2019, then declined by 3.71% to $3.3 million in 2020, then sank by 57.49% to $1.4 million in 2021.
• The last three Current Leases figures came in at $1.4 million (Q1 2021), $3.3 million (Q4 2020), and $3.1 million (Q3 2020), per Business Quant data.